Discover
KTTA
Pasithea Therapeutics Corp.
0.52
2 x 0.35
2 x 0.65
bid
ask
+
0.02
3.36%
2 @ 04:00 PM
0.49 -0.03 (5.86%)
| Ytd | -59.40% | |
| 1y | -27.26% |
0.49
day range
0.55
0.28
52 week range
2.06
| Open | 0.53 | Prev Close | 0.51 | Low | 0.49 | High | 0.55 | Mkt Cap | 17.50M |
| Vol | 483.38K | Avg Vol | 695.77K | EPS | -1.35 | P/E | N/A | Forward P/E | -3.75 |
| Beta | 0.82 | Short Ratio | 0.32 | Inst. Own | 2.87% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-16 | 50-d Avg | 0.50 | 200-d Avg | 0.73 | 1yr Est | 2.00 |
KTTA News
benzinga.com
12 Health Care Stocks Moving In Friday's After-Market Session
Gainers DataMEDS AI (NASDAQ:MEDS) shares increased by 12.9% to $4.24 during Friday's after-mark
benzinga.com
Pasithea Sets November Debut For Early PAS-004 Clinical Trial Results
Pasithea Therapeutics Corp. (NASDAQ:KTTA) ("Pasithea" or the "Company"), a clinical-
globenewswire.com
Pasithea Therapeutics Announces Presentation of Initial PAS-004 Clinical Data from Ongoing Phase 1/1
- Pasithea has been selected to present cutaneous neurofibromas (CN) clinical data in an oral presen
benzinga.com
12 Health Care Stocks Moving In Friday's After-Market Session
Gainers Picard Medical (AMEX:PMI) stock rose 40.2% to $4.5 during Friday's after-market session